Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optimi Health Corp (OPTI.CN)

Optimi Health Corp (OPTI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,435
  • Shares Outstanding, K 91,033
  • Annual Sales, $ 181 K
  • Annual Income, $ -5,195 K
  • 60-Month Beta 1.47
  • Price/Sales 105.74
  • Price/Cash Flow N/A
  • Price/Book 2.71
Trade OPTI.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.02 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2950 unch
on 07/02/24
0.5400 -45.37%
on 06/03/24
-0.1350 (-31.40%)
since 05/31/24
3-Month
0.2250 +31.11%
on 04/04/24
0.5400 -45.37%
on 06/03/24
+0.0500 (+20.41%)
since 04/02/24
52-Week
0.1500 +96.67%
on 12/12/23
0.5800 -49.14%
on 01/03/24
+0.0700 (+31.11%)
since 06/30/23

Most Recent Stories

More News
Optimi Health and Mind Medicine Australia Launch OptiMed Prescriber Portal for Australian Psychiatrists

Vancouver, British Columbia--(Newsfile Corp. - June 27, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-approved, GMP-compliant pharmaceutical...

OPTHF : 0.2188 (-9.92%)
OPTI.CN : 0.2950 (-10.61%)
Health Canada Issues Three Export Permits to Optimi to Supply Patients Under Australia's Authorised Prescriber Scheme

The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD and Treatment-Resistant Depression.Vancouver, British Columbia--(Newsfile Corp....

OPTHF : 0.2188 (-9.92%)
OPTI.CN : 0.2950 (-10.61%)
Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a leading Health Canada licensed GMP psychedelics...

OPTHF : 0.2188 (-9.92%)
OPTI.CN : 0.2950 (-10.61%)
Optimi Health Awarded Drug Establishment Licence From Health Canada

/CNW/ - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), a leading Health Canada-licensed psychedelics pharmaceutical...

OPTI.CN : 0.2950 (-10.61%)
OPTHF : 0.2188 (-9.92%)
Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing

/CNW/ - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufacturer specializing...

OPTI.CN : 0.2950 (-10.61%)
OPTHF : 0.2188 (-9.92%)
Early Warning Press Release in Accordance with National Instrument 62-103

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Issuer")...

OPTI.CN : 0.2950 (-10.61%)
Stocks in play: Optimi Health Corp

Announces the completion of its proprietary preclinical MDMA drug candidate OPTI-MHCL for use in drug ...

OPTI.CN : 0.2950 (-10.61%)
Stocks in play: Optimi Health Corp

Announces the expansion of its sales network in Canada. To further scale the sales and distribution ...

OPTI.CN : 0.2950 (-10.61%)
Psychedelic Drugs Prove Their Worth In Clinical Trials

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan...

OPTI.CN : 0.2950 (-10.61%)
ATAI : 1.3000 (-3.70%)
MNMD : 6.96 (-1.56%)
MMED.NE : 14.9000 (+9.48%)
CMPS : 5.96 (+0.17%)
OPTHF : 0.2188 (-9.92%)
CYBN : 0.2649 (-0.04%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical...

OPTI.CN : 0.2950 (-10.61%)
SEEL : 0.5800 (-6.30%)
NUMI.TO : 0.0450 (unch)
NUMIF : 0.0342 (unch)
ATAI : 1.3000 (-3.70%)
OPTHF : 0.2188 (-9.92%)
TNXP : 0.7370 (+0.68%)
TAK : 13.03 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate,...

See More

Key Turning Points

3rd Resistance Point 0.3533
2nd Resistance Point 0.3417
1st Resistance Point 0.3183
Last Price 0.2950
1st Support Level 0.2833
2nd Support Level 0.2717
3rd Support Level 0.2483

See More

52-Week High 0.5800
Fibonacci 61.8% 0.4157
Fibonacci 50% 0.3650
Fibonacci 38.2% 0.3143
Last Price 0.2950
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar